Molecular recognition technology for better antibodies

A Nanobody discovery platform to transform the discovery and development of antibody-based therapeutics and diagnostics.

Biocognon’s Nanobody discovery platform is based on patented fluorogen activating proteins that report specific binding between a yeast surface displayed Nanobody and a target antigen secreted from the same cell.